Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Calyxt Inc (CLXT)

Calyxt Inc (CLXT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 31,334
  • Shares Outstanding, K 4,974
  • Annual Sales, $ 160 K
  • Annual Income, $ -16,890 K
  • 60-Month Beta 2.04
  • Price/Sales 189.13
  • Price/Cash Flow N/A
  • Price/Book 11.75
Trade CLXT with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -4.39
  • Most Recent Earnings $-1.09 on 05/01/23
  • Latest Earnings Date 05/04/23
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/23
See More
  • Average Estimate -0.60
  • Number of Estimates 1
  • High Estimate -0.60
  • Low Estimate -0.60
  • Prior Year -1.40
  • Growth Rate Est. (year over year) +57.14%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.64 +138.64%
on 05/01/23
7.77 -18.92%
on 05/31/23
+3.27 (+107.92%)
since 04/28/23
3-Month
2.41 +161.19%
on 04/12/23
7.77 -18.92%
on 05/31/23
+2.10 (+49.96%)
since 02/28/23
52-Week
1.25 +404.00%
on 11/04/22
7.77 -18.92%
on 05/31/23
+2.98 (+89.87%)
since 05/27/22

Most Recent Stories

More News
Calyxt Announces Stockholder Approval of Merger With Cibus

/PRNewswire/ -- Calyxt, Inc. (Nasdaq: CLXT) ("Calyxt" or the "Company") today announced the results of the special meeting of its stockholders held on May 18,...

CLXT : 6.30 (+5.53%)
Calyxt Reports First Quarter 2023 Financial Results and Provides Corporate Update

/PRNewswire/ -- Calyxt, Inc. (Nasdaq: CLXT), a plant-based synthetic biology company, today announced operating and financial results for its first quarter...

CLXT : 6.30 (+5.53%)
Calyxt Completes One-for-Ten Reverse Stock Split

/PRNewswire/ -- Calyxt, Inc. (Nasdaq: CLXT) ("Calyxt" or the "Company") today announced that it has completed the previously announced reverse stock split of...

CLXT : 6.30 (+5.53%)
Calyxt Announces Effective Date of Reverse Stock Split

/PRNewswire/ -- Calyxt, Inc. (Nasdaq: CLXT) ("Calyxt" or the "Company") today announced that it will proceed with the 1-for-10 reverse stock split previously...

CLXT : 6.30 (+5.53%)
CALYXT INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Merger of Calyxt, Inc. - CLXT

/PRNewswire/ -- Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC ("KSF") are investigating the...

CLXT : 6.30 (+5.53%)
Calyxt Reports Fourth Quarter 2022 Financial Results and Provides Corporate Update

/PRNewswire/ -- Calyxt, Inc. (Nasdaq: CLXT), a plant-based synthetic biology company, today announced operating and financial results for its fourth quarter...

CLXT : 6.30 (+5.53%)
Calyxt, Inc. Announces its Filing of Registration Statement on Form S-4 in Connection with Merger with Cibus Global LLC

/PRNewswire/ -- Calyxt, Inc. (Nasdaq: CLXT), a plant-based synthetic biology company, and Cibus, a leader in precision gene editing in agriculture, today...

CLXT : 6.30 (+5.53%)
SHAREHOLDER ALERT: Weiss Law Reminds CLXT, BRBW, MPB, and COUP Shareholders About Its Ongoing Investigations

/PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this...

CLXT : 6.30 (+5.53%)
MPB : 19.52 (+1.67%)
COUP : 80.97 (+0.78%)
CALYXT INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Calyxt, Inc. - CLXT

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of Calyxt, Inc. (“the Company”) (NasdaqCM:...

CLXT : 6.30 (+5.53%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CBIO, HZN, CLXT, VLTA

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

CBIO : 7.6695 (-2.65%)
HZN : 1.7600 (unch)
CLXT : 6.30 (+5.53%)
VLTA : 0.8590 (-0.01%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy and ranks in the Top 1% of all short term signal directions.

Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Business Summary

Calyxt is a plant-based synthetic biotechnology company. The Company leverages its proprietary PlantSpring (TM) technology platform to engineer innovative materials and products for its customers to help them meet their sustainability goals. Calyxt's diversified offerings are primarily delivered through...

See More

Key Turning Points

3rd Resistance Point 9.14
2nd Resistance Point 8.45
1st Resistance Point 7.38
Last Price 6.30
1st Support Level 5.62
2nd Support Level 4.93
3rd Support Level 3.86

See More

52-Week High 7.77
Last Price 6.30
Fibonacci 61.8% 5.28
Fibonacci 50% 4.51
Fibonacci 38.2% 3.74
52-Week Low 1.25

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar